>>Remember the interim goal of this Company was to penetrate the...

>>Remember the interim goal of this Company was to penetrate the diagnostics market over the next couple of years in a big way. Revenue streams from this set of markets could be expected to exceed $100million pa easily should the product continue to yield favourable feedback.

Bank most of that and you could well be looking at $1 share price on the Diagnostics Industry alone.

Its many other commercial applications could very well multiply this figure.

So yes we all wait with baited breath as to a sign of more positive developments. But do not loose sight of the potential impact current unterflowing revenue streams may already be having on this Company's valuation.

Anyone involved in Commercial agreements and discussions knows it can take time. I guess its up to the individual as to how much time they are prepared to wait. Given the potential re-rating effects of new deals, this little investor is here for the long run.<<

100 mil pa will price this play conservatively at a MC of 1 billion. Being $1.90 ps. Some more sales forecasts from the company will be great to see whether the diagnostic market is worth this would be great.

Type in Mix N Go and you can see that the marketing is now in full swing. Great products, great price, in a forever growing market...